Tianjin Pharmaceutical Da Ren Tang Group Dividends and Buybacks
Dividend criteria checks 2/6
Tianjin Pharmaceutical Da Ren Tang Group is a dividend paying company with a current yield of 3.98%.
Key information
4.0%
Dividend yield
0.1%
Buyback Yield
| Total Shareholder Yield | 4.1% |
| Future Dividend Yield | 4.0% |
| Dividend Growth | 16.5% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | US$0.239 |
| Payout ratio | 106% |
Recent dividend and buyback updates
Recent updates
Is Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) A Risky Investment?
Nov 03
Is Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SGX:T14) Expensive For A Reason? A Look At Its Intrinsic Value
Aug 08Should You Be Adding Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) To Your Watchlist Today?
Jul 21We Think Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) Can Manage Its Debt With Ease
Jun 20If EPS Growth Is Important To You, Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) Presents An Opportunity
Apr 17Calculating The Intrinsic Value Of Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SGX:T14)
Mar 01Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) Has A Pretty Healthy Balance Sheet
Feb 03Stability and Growth of Payments
Fetching dividends data
Stable Dividend: T14's dividend payments have been volatile in the past 10 years.
Growing Dividend: T14's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Tianjin Pharmaceutical Da Ren Tang Group Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (T14) | 4.0% |
| Market Bottom 25% (SG) | 2.7% |
| Market Top 25% (SG) | 5.9% |
| Industry Average (Pharmaceuticals) | 1.8% |
| Analyst forecast (T14) (up to 3 years) | 4.0% |
Notable Dividend: T14's dividend (3.98%) is higher than the bottom 25% of dividend payers in the SG market (2.7%).
High Dividend: T14's dividend (3.98%) is low compared to the top 25% of dividend payers in the SG market (5.92%).
Earnings Payout to Shareholders
Earnings Coverage: With its high payout ratio (105.8%), T14's dividend payments are not well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its high cash payout ratio (95%), T14's dividend payments are not well covered by cash flows.